Abstract
The efficacy of drug-eluting stent (DES) implantation for the femoropopliteal (FP) disease in the real world is not yet clarified compared with bare metal nitinol stent (BMS). Between January 2004 and April 2013, 1150 consecutive patients who had received their first endovascular therapy for FP
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
